Trial | NCT00666042  Report issue

Title

Bioequivalence of Eye Drops and Spray Administration of Vigamox
Laboratory-masked, Randomized Parallel, Comparative, Pilot Study on the Bioavailability of Vigamox in the Aqueous Humor When Administered Either as Commercially Available Eye Drops or in a Spray Form

  • Phase

    N/A

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Intervention/Treatment

    moxifloxacin ...

  • Study Participants

    16
The study compares the amounts of Vigamox absorbed when administered as eye drops or in a spray form. Both administrations will be prior to patients undergoing elective cataract surgery and the aqueous samples will be analyzed by a laboratory in a masked fashion. The hypothesis is that there will be no difference between the 2 modes of administration.
Study Started
Feb 28
2009
Primary Completion
Apr 30
2009
Study Completion
May 31
2009
Last Update
Jan 19
2012
Estimate

Drug Vigamox - administration in spray form

Vigamox will be administered in a spray form

Drug Vigamox eye drops

Vigamox eye drops

A Experimental

Vigamox delivered as spray

B Active Comparator

Patients will receive the commercially available Vigamox drops

Criteria 

Inclusion Criteria:

Patients scheduled for elective cataract surgery

Exclusion Criteria:

Allergy to Vigamox
No Results Posted